ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2276

Consensus Statement on the Transition Process from Pediatric Care to Adult Care in Patients with Chronic Inflammatory Rheumatic Diseases with Childhood-Onset

Maria Inmaculada Calvo-Penedes1, Jordi Anton Lopez2, Sagrario Bustabad-Reyes3, Marisol Camacho4, Jaime De Inocencio5, Maria Luz Gamir Gamir6, Genaro Graña7, Lucía La Cruz8, Juan Carlos Lopez-Robledillo9, Marta Medrano10, Rosa Merino11, Consuelo Modesto12, Esmeralda Nuñez13, Maria Jesus Rua Elorduy14, Vicente Torrente15, Carmen Vargas-Lebrón16 and Estibaliz Loza17, 1Avda. Campanar, 21, H. de la Fe, Valencia, Spain, 2pediatric Rheumatology, University Childrenxs Hospital, Barcelona, Spain, 3Rheumatology, Hospital Universitario de Canarias, La Laguna, Spain, 4Hospital Universitario Virgen del Rocío, Sevilla, Spain, 5Hospital 12 de Octubre, Madrid, Spain, 6Hospital Universitario Ramón y Cajal, Madrid, Spain, 7Rheumatology, Complejo Hospitalario Universitario A Coruña, La Coruña, Spain, 8Hospital Universitari Son Dureta, Mallorca, Spain, 9Hospital Niño Jesus, Madrid, Spain, 10Rheumatology, Hospital Universitario Miguel Servet, Zaragoza, Spain, 11Hospital Universitario La Paz, Madrid, Spain, 12Hospital Valle de Hebron, Barcelona, Spain, 13Hospital Regional Universitario Carlos Haya, Málaga, Spain, 14Pediatric Rheumatology, Hospital de Cruces, Barakaldo, Spain, 15Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain, 16Rheumatology, Hospital Virgen Macarena, Seville, Spain, 17Institu, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Transition and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Systemic Juvenile Idiopathic Arthritis, Spondyloarthropathy and Miscellaneous Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: many young people with childhood-onset diseases, including rheumatic diseases, continue to require medical care into adult life. There are many differences between pediatric and adult health care. Although there is an extensive evidence base for the need of transitional care, there is a paucity of robust outcome data and a great variability on the models of transitional care. The aim of this study was to develop recommendations on the transition from pediatric care to adult care in patients with chronic inflammatory rheumatic diseases with childhood-onset based on the best evidence and experience.

Methods: recommendations were generated following nominal group methodology and Delphi technique. A panel of experts was established (8 pediatricians, 8 rheumatologists). A systematic literature review (on transitional care) and a narrative review (websites, clinical guidelines and other relevant documentation) were performed and presented to the panel in the 1st panel meeting to be discussed and to help define recommendations. A first draft of recommendations was generated and circulated for comments and wording refinements. Focal groups with adolescents, young adults and parents were separately. In a 2nd panel meeting the focus group results along with the input from invited psychologist was used to established definitive recommendations. Then, a Delphi process (2 rounds) was carried out. A large group of 70 pediatricians and rheumatologists took part. Recommendations were voted from 1 (total disagreement) to 10 (total agreement). We defined agreement if at least 70% voted ≥7. The level of evidence and grade or recommendation was assessed using the Oxford Centre for Evidence-based Medicine Levels of Evidence. 

Results: transition care was defined as a purposeful, planned process that addresses the medical, psychosocial and educational/vocational needs of adolescents and young adults with chronic inflammatory rheumatic diseases with childhood-onset as they move from child-centred to adult-oriented health care systems. The consensus covers: transition needs, barriers and facilitators, transitional issues (objectives, participants, content, phases, timing, plans, documentation, and responsibilities), physicians and other health professionals knowledge and skills requirements, models/programs, strategies and guideline for implementation. Preliminary recommendations and agreement grade are shown in the table (1st Delphi round).  

Conclusion: these recommendations are intended to provide pediatricians, rheumatologists, patients, families and other stakeholders with a consensus on the transition process from pediatric care to adult care in patients with chronic inflammatory rheumatic diseases with childhood-onset.

 

#

RECOMMENDATIONS

% ≥7

1

Transition in pediatric rheumatology should be considered as a continuous, natural and flexible process

92%

2

To standardize, plan ahead, and to define specific protocols related to transitional care

94%

3

To promote outpatient care during transition

47%

4

To endorse specialized nursing care during transition 

88%

5

During transitional care, health professionals should convey to patients and parents normality, optimism, sincerity, and should listen to and dialog with them efficiently   

97%

6

To  support and reinforce patients autonomy and participation adapted to the age/maturity of them during transition

99%

7

To facilitate (evidence based) useful written information (electronic, paper) about disease most relevant issues, management and other aspects for patients and parents

91%

8

To actively involve patients and parents in all of the processes of the transitional care

94%

9

To inform patients and parents about the disease and transitional processes including adult care

99%

10

To monitor adherence (to treatments, visits, etc)

90%

11

To endurance effective communication, collaboration and coordination, among all health professionals involved in the transitional care

78%

12

To endurance effective communication, collaboration and coordination, between health professionals involved in the transitional care and patients educators

64%

13

To develop clinical sessions between pediatric rheumatologists and adult rheumatologists and with other specialists involved in transitional care

90%

14

Adaptations to patients academic needs should be considered  

34%

15

An specific training on transitional care as a part of the pediatric training

58%

16

To promote multidisciplinary care by implementing a transitional care model based on each center characteristics, resources and needs

97%

17

The implementation of a transition care model should be planned carefully as well as the strategies to assure the implementation

94%

18

When transferring a patient to the adult care, a full report on the disease course, impact, treatments, and other relevant aspects should be delivered

100%

19

To  set up reference units of transitional care

37%


Disclosure:

M. I. Calvo-Penedes,

Abbvie Spain S.L.U.,

2,

Pfizer Inc,

2,

Roche Pharmaceuticals,

2,

Bristol-Myers Squibb,

2,

Novartis Pharmaceutical Corporation,

2;

J. A. Lopez,

Abbvie, Novartis, Pfizer,

2,

Novartis Pharmaceutical Corporation,

5,

Abbvie, Novartis, Pfizer, Roche, SOBI,

8;

S. Bustabad-Reyes,
None;

M. Camacho,
None;

J. De Inocencio,

Gebro,

2,

Bristol-Myers Squibb,

8,

Abbvie,

8,

Pfizer Inc,

8;

M. L. Gamir Gamir,
None;

G. Graña,
None;

L. La Cruz,
None;

J. C. Lopez-Robledillo,
None;

M. Medrano,
None;

R. Merino,
None;

C. Modesto,
None;

E. Nuñez,
None;

M. J. Rua Elorduy,
None;

V. Torrente,
None;

C. Vargas-Lebrón,

Roche Pharmaceuticals,

8,

Pfizer Inc,

8,

Abbvie,

8;

E. Loza,

Roche Pharmaceuticals,

2,

Merck Pharmaceuticals,

2,

Abbott Immunology Pharmaceuticals,

2,

Pfizer Inc,

2.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/consensus-statement-on-the-transition-process-from-pediatric-care-to-adult-care-in-patients-with-chronic-inflammatory-rheumatic-diseases-with-childhood-onset/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology